← Back to Search
Leukotriene B, A Potent Chemokinetic And Aggregating Substance Released From Polymorphonuclear Leukocytes
A. Ford-Hutchinson, M. Bray, M. Doig, M. E. Shipley, M. Smith
Published 1980 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Arachidonic acid is metabolised either by cyclooxygenases to produce prostaglandins and thromboxanes or by lipoxygenases to produce mono-, di- and trihydroxyeicosatetraenoic acids (HETEs). Polymorphonuclear leukocytes (PMNs) release HETEs, including mono- and dihydroxy fatty acids, when exposed to stimuli such as the cakvim ionophore A23187 (refs 1, 2). The mono-HETEs are assumed to be of particular importance with respect to effects on leukocyte function because they have been shown to possess both chemotactic and chemokinetic activities towards PMNs and eosinophils3,4. However, we have now shown that the chemokinetic and aggregating activities released from rat and human PMNs exposed to ionophore A23187 (ref. 5) are not due to the release of mono-HETEs but to that of 5,12-di-HETE (leukotriene B). This compound is active over the concentration range 10 pg ml−1 to 5 ng ml−1.
This paper references
Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils
E. Goetzl (1979)
The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs).
E. Goetzl (1980)
Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187.
P. Borgeat (1979)
Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids.
W. Stenson (1979)
Inhibition of the neutrophil oxidative response to a chemotactic peptide by inhibitors of arachidonic acid oxygenation.
G. Bokoch (1979)
Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds.
P. Borgeat (1979)
Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. Formation of a novel dihydroxyeicosatetraenoic acid.
P. Borgeat (1979)
Aggregation of rat polymorphonuclear leucocytes in vitro
F. Cunningham (1980)
This paper is referenced by
THE ROLE OF LIPOXYGENASE PRODUCTS OF ARACHIDONIC ACID IN INFLAMMATORY EVENTS MEDIATED BY HUMAN BASOPHILS AND MAST CELLS
S. Peters (1983)
Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery.
K. Prasad (1992)
High performance liquid chromatography (HPLC) of arachidonic acid metabolites.
J. Hamilton (1982)
A radioimmunoassay for leukotriene B4.
J. A. Salmon (1982)
Synthesis of leukotrienes and lipoxygenase products
J. Rokach (1985)
Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease.
P. Sharon (1985)
Prostaglandins and other metabolites of arachidonic acid. An overview for the otolaryngologist.
M. Poole (1985)
Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction.
A. Evers (1985)
Mechanism of oxygen toxicity in rat lungs
Masaru Iwata (2007)
5-lipoxygenase from rat PMN lysate.
M. T. Skoog (1986)
9 formation in the gastrointestinal tract and effects of anti-inflammatory drugs
Dreyling Kw (1987)
The metabolism "in vitro" of leukotriene B4 in blood of normal subjects and asthmatic patients.
J. Zakrzewski (1988)
Therapeutic Aspects of Leukotriene Antagonists and Inhibitors
A. Ford-Hutchinson (1991)
Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor
A. Rossi (2006)
Inflammatory mediators in the critically ill
J. Herdegen (1992)
Eicosanoids in Trauma and Traumatic Shock
H. Neuhof (1993)
Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures.
P. Conti (1992)
Release of leukotrienes and histamine by the isolated anaphylactic heart.
H. Salari (1987)
Molecular cloning and expression of canine interleukin 8 cDNA.
Y. Matsumoto (1994)
Role of lipoxygenase metabolites in platelet-activating factor- and antigen-induced bronchial hyperresponsiveness and eosinophil infiltration.
E. Seeds (1995)
Leukotriene B4 Receptor-1 Is Essential for Allergen-Mediated Recruitment of CD8+ T Cells and Airway Hyperresponsiveness1
N. Miyahara (2005)
The Short and Happy Life of Neutrophil Activation
E. L. Becker (1990)
The effect of acute feeding of carnitine, acetyl carnitine and propionyl carnitine on basal and A23187-stimulated eicosanoid release from rat carrageenan-elicited peritoneal macrophages.
G. Elliott (1990)
International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions
M. Bäck (2011)
Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5‐lipoxygenase inhibitor (ABT‐761) in healthy volunteers
S. Wong (1998)
Leucocyte activation markers in clinical practice.
J. V. Contreras (1999)
Exacerbation of pustulosis palmaris et plantaris after topical application of metals accompanied by elevated levels of leukotriene B4 in pustules.
K. Nakamura (2000)
Co-localization of Leukotriene A4Hydrolase with 5-Lipoxygenase in Nuclei of Alveolar Macrophages and Rat Basophilic Leukemia Cells but Not Neutrophils*
T. Brock (2001)
A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD.
S. Gompertz (2002)
Interleukin‐8 induces changes in human neutrophil actin conformation and distribution: relationship to inhibition of adhesion to cytokine‐activated endothelium
W. Westlin (1992)
5-oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin.
S. Muro (2003)
Human C1 esterase inhibitor attenuates murine mesenteric ischemia/reperfusion induced local organ injury.
Georg Karpel-Massler (2003)See more